1.4 million Canadians report long COVID symptoms, says StatCan

المملكة العربية السعودية أخبار أخبار

1.4 million Canadians report long COVID symptoms, says StatCan
المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين
  • 📰 BurnabyNOW_News
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 77%

“People are hurting,” said Susie Goulding, a long-COVID patient and founder of the COVID Long-Haulers Support Group Canada.

Nearly 15 per cent of Canadians who tested positive or suspect they had COVID-19 say they have been hit by long-term symptoms of the disease.

“Canada must act now in a strategic manner to help ease the burden of long COVID on our healthcare systems, on our economy and on the lives of those who are struggling,” said Dr. Stan Kutcher, a psychiatrist and independent senator for Nova Scotia, in a written statement. Recent research tracking the electronic records of more than 270,000 confirmed COVID-19 survivors found over 36 per cent had one or more long COVID symptoms three months after they were infected.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

BurnabyNOW_News /  🏆 14. in CA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

U.S. clears Novavax COVID booster doseU.S. clears Novavax COVID booster doseU.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax.
اقرأ أكثر »

COVID-19 vaccine hesitancy among Sask. parents still a top concern, epidemiologist says | Globalnews.caCOVID-19 vaccine hesitancy among Sask. parents still a top concern, epidemiologist says | Globalnews.caA report by Saskatchewan report on vaccine hesitancy among parents offers recommendations on local, provincial and federal levels to encourage uptake of children's COVID-19 shots.
اقرأ أكثر »

Health Canada approves drug to treat COVID-19 in immunocompromised patients, AstraZeneca says | CBC NewsHealth Canada approves drug to treat COVID-19 in immunocompromised patients, AstraZeneca says | CBC NewsSome people in Canada who are particularly vulnerable to illness from COVID-19 have a new treatment option. The antibody-based therapy Evusheld previously used to prevent the virus can now also be used as a treatment.
اقرأ أكثر »

Myocarditis risk is seven times greater with COVID-19 than vaccinesMyocarditis risk is seven times greater with COVID-19 than vaccinesHeartInflammation can lead to blood clots in your heart that cause stroke or heart attack, and can be fatal. – via healthing_ca Myocarditis healthing healthnews COVID vaccine
اقرأ أكثر »

Myocarditis risk is seven times greater with COVID-19 than vaccinesMyocarditis risk is seven times greater with COVID-19 than vaccinesHeartInflammation can lead to blood clots in your heart that cause stroke or heart attack, and can be fatal. – via healthing_ca Myocarditis healthing healthnews COVID vaccine
اقرأ أكثر »



Render Time: 2025-04-20 13:27:09